Global AI In Digital Pathology Market Size Likely to Grow at a CAGR of 18.02% By 2035

Market Size and Growth

The global AI in digital pathology market size was valued at USD 1.15 billion in 2026 and is expected to grow at a compound annual growth rate (CAGR) of 18.02% from 2026 to 2035 to reach USD 5.14 billion by 2035.

Global AI in digital pathology Market Revenue and Trends

AI in Digital Pathology market definition: The market includes AI (artificial intelligence), machine learning (ML), deep learning (DL), computer vision (CV), cloud computing, WSI (whole slide imaging), digital image management systems, and advanced pathology analytics technology and solutions to aid in disease diagnosis, enhance workflows, and support precision medicine.

AI in digital pathology enables automating the analysis of images, detecting tumors, quantifying the biomarkers, enhancing the pathology workflow, and assisting clinicians in making decisions.

AI -powered solutions are penetrating pathology labs, hospitals, cancer research institutes, and pharma industries for improved accuracy in disease identification, early detection of cancer, and personalized cancer treatment. The global AI in digital pathology market is propelled by growing digital labs in pathology and imaging, growing cancer incidence and need for personalized treatment, rising usage of WSI and digital image analysis software, increasing usage in academic institutions for teaching and research purposes, and supportive regulatory approvals for AI in clinical decisions.

What are the key drivers for the global AI in digital pathology market?

The worldwide AI-enabled digital pathology market growth is due to the increasing need to facilitate faster, highly accurate, and standardized diagnostic pathology. Healthcare organizations are rapidly adopting AI-enabled digital pathology platforms globally, including various AI-driven pathology analyses for the diagnosis of cancer, the classification of tissue types, enumeration of biomarkers, identification of metastatic cells, and the reduction of variability in diagnoses.

The growing incidence of cancer and other lifestyle diseases globally, the deficiency of trained pathologists, and the rising number of tasks associated with pathological processes are prompting healthcare companies to introduce the intelligent digital pathology solution which enhances the accuracy, diagnosis efficiency and productivity of laboratory operations while reducing turnaround time.

Moreover, the rise in the adoption of telepathology and remote consultation, as well as integrated laboratory information systems (LIS), etc., paves the way for large market penetration. The rapid progress made in the areas of Artificial Intelligence(AI), deep learning, computer vision, cloud-based pathology, as well as multimodal data analytics is revolutionizing how digital pathology workflows can be carried out.

The current AI algorithms are being adopted globally for analyzing gigapixelwhole-slidesimages(WSI), linking together the features found in histopathology images with genetic and clinical data, as well as for the analysis of Companion Diagnostics(CDx), to perform a precision oncology screening using automatically generated biomarkers. In addition, significant investments from stakeholders in health providers, the pharmaceutical industry, a few research institutes, and many technology vendors have been poured into digital pathology infrastructure development, along with AI assisted clinical research, drug development, and precision medicine approaches and thus will lead to significant growth opportunities in the AI in digital pathology market.

Opportunities Impact Analysis

Challenges Impact Analysis

Segment Insight

By Component Software

The biggest segment in 2023 saw an increase in the adoption of AI-powered image analysis, computational pathology, workflow automation, and diagnostic decision support. The rise in the widespread use of whole-slide image analysis, biomarker quantification, and cloud-based pathology platforms is driving demand for software and is expected to rise with an increase in hardware and services.

By Technology Deep Learning

The largest segment in 2023 with a number of widespread applications and the capability of analyzing whole slide images, classifying tissue, detecting tumors and quantifying biomarker expression. Improvements in CNN, ViT, and foundation models will also boost market growth.

By Deployment Mode Cloud

largest segment in 2023 with secure data storage, scalability, availability, and integration of workflow capabilities. Facilitating safe storage and analysis of vast whole slide images, telepathology, AI processing and sharing of data across sites with cost-efficiency and ease of deployment and scalability.

By Application Cancer Detection & Classification

The largest segment in 2023 has the prevalence of cancer globally and an increase in the use of AI-assisted pathology to detect tumors, grade them, test for biomarkers, and help patients manage their diseases. Growing acceptance of companion diagnostics to implement precision oncology in hospitals and cancer centers is aiding the expansion of this market.

By Disease Indication Breast Cancer

The leading disease indication for the digital pathology AI market due to the increasing prevalence and strong adoption for the diagnosis, biomarker testing, tumor grading, and personal treatment approaches for the condition. Expanding cancer screening initiatives and a focus on precision medicine are fueling growth.  

Regional Insights

• North America: Market leader by 2023, the strong digital pathology infrastructure, widespread adoption of whole slide imaging, ease of doing business and positive regulatory support are some factors driving demand for the digital pathology AI solutions. Additionally, the presence of leading vendors of pathology technology, pharmaceutical companies, academic medical centers, and research institutes, as well as an increasing focus on AI in precision medicine, are adding to market expansion.

• Asia Pacific: Fastest growing market region, fueled by increasing incidence of cancer, digital health infrastructure, and increasing investments in AI and precision medicine. The region offers significant potential owing to a rapid surge in healthcare IT, digitalization efforts, expansion of pathology lab infrastructure, increasing awareness of advanced diagnostics, and widespread use of mobile and cloud technologies for accessing healthcare services across countries like China, India, Japan, South Korea, Singapore, and Australia.

Report Scope

Recent Developments

• June 2025: The AI pathology company PathAI expanded its AI pathology offerings through novel partnerships with pharma firms aiming to expedite biomarker discovery and the creation of companion diagnostic tools to advance cancer trials.

List of the prominent players in the AI in Digital Pathology Market:

• Leica Biosystems (Danaher Corporation)

• Philips Healthcare

• Roche Diagnostics

• Hamamatsu Photonics

• Fujifilm Holdings Corporation

• Olympus Corporation

• Indica Labs

• Paige AI

• PathAI

• Ibex Medical Analytics

• Aiforia Technologies Plc

• Proscia Inc.

• Visiopharm A/S

• Mindpeak GmbH

• Techcyte Inc.

• Tempus AI

• Deep Bio Inc.

• Other

The AI In Digital Pathology Market is segmented as follows:

By Component

• Software

• Hardware

• Services

By Technology

• Machine Learning (ML)

• Deep Learning

• Computer Vision

• Natural Language Processing (NLP)

• Generative AI & Foundation Models

By Deployment Mode

• On-Premises

• Cloud-Based

• Hybrid

By Application

• Disease Diagnosis

• Cancer Detection & Classification

• Biomarker Detection & Quantification

• Drug Discovery & Development

• Clinical Workflow Management

• Companion Diagnostics

• Research & Education

By Disease Indication

• Breast Cancer

• Prostate Cancer

• Lung Cancer

• Colorectal Cancer

• Gastrointestinal Diseases

• Hematological Disorders

• Infectious Diseases

• Neurological Disorders

• Others

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America